Perceived impact of continuous glucose monitor use on quality of life and self-care for patients with type 2 diabetes

Evidence for clinical and quality of life benefits of Continuous Glucose Monitor (CGM) use in patients with type 1 diabetes (T1DM) is well established, but evidence in patients with type 2 diabetes (T2DM) is less robust or clear. This study aimed to help clarify the impact of CGMs for patients with...

Full description

Bibliographic Details
Main Authors: Amanda R. Johnston, PharmD, Justin B. Poll, Ph.D, Emily M. Hays, PharmD, Christopher W. Jones, MD
Format: Article
Language:English
Published: Elsevier 2022-04-01
Series:Diabetes Epidemiology and Management
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666970622000191